eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
14.72
-0.28 (-1.84%)
At close: Dec 5, 2025, 4:00 PM EST
14.85
+0.13 (0.85%)
After-hours: Dec 5, 2025, 4:00 PM EST
eXoZymes Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | - | - | 0.07 | - | - |
| Other Revenue | - | - | - | 0.03 | - |
| Revenue | - | - | 0.07 | 0.03 | - |
| Revenue Growth (YoY) | - | - | 145.01% | - | - |
| Gross Profit | - | - | 0.07 | 0.03 | - |
| Selling, General & Admin | 5.78 | 4.06 | 1.34 | 0.98 | 0.84 |
| Research & Development | 3.23 | 1.87 | 0.53 | 0.38 | 0.45 |
| Operating Expenses | 9 | 5.93 | 1.87 | 1.36 | 1.29 |
| Operating Income | -9 | -5.93 | -1.8 | -1.33 | -1.29 |
| Interest & Investment Income | 0.38 | 0.08 | 0 | 0 | - |
| Other Non Operating Income (Expenses) | 0.28 | -0.01 | -0.2 | - | - |
| EBT Excluding Unusual Items | -8.34 | -5.86 | -2 | -1.33 | -1.29 |
| Other Unusual Items | - | - | - | - | 0.08 |
| Pretax Income | -8.34 | -5.86 | -2 | -1.33 | -1.21 |
| Income Tax Expense | -0 | - | 0.04 | 0.06 | - |
| Net Income | -8.34 | -5.86 | -2.04 | -1.4 | -1.21 |
| Net Income to Common | -8.34 | -5.86 | -2.04 | -1.4 | -1.21 |
| Shares Outstanding (Basic) | 8 | 7 | 6 | 6 | 5 |
| Shares Outstanding (Diluted) | 8 | 7 | 6 | 6 | 5 |
| Shares Change (YoY) | 30.51% | 5.01% | 4.72% | 15.14% | - |
| EPS (Basic) | -1.02 | -0.89 | -0.33 | -0.23 | -0.23 |
| EPS (Diluted) | -1.02 | -0.89 | -0.33 | -0.23 | -0.23 |
| Free Cash Flow | -10.54 | -8.9 | -1.47 | -1.44 | -2.01 |
| Free Cash Flow Per Share | -1.29 | -1.36 | -0.23 | -0.24 | -0.39 |
| Gross Margin | - | - | 100.00% | 100.00% | - |
| Operating Margin | - | - | -2563.51% | -4660.00% | - |
| Profit Margin | - | - | -2909.12% | -4881.91% | - |
| Free Cash Flow Margin | - | - | -2097.34% | -5046.08% | - |
| EBITDA | -8.72 | -5.66 | -1.6 | -1.18 | -1.23 |
| D&A For EBITDA | 0.28 | 0.27 | 0.2 | 0.15 | 0.06 |
| EBIT | -9 | -5.93 | -1.8 | -1.33 | -1.29 |
| Revenue as Reported | - | - | - | 0.03 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.